data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Capricor Therapeutics
(NASDAQ:CAPR)
$3.68
0.19[5.44%]
At close: Jul 1
$3.49
-0.1900[-5.16%]
After Hours: 5:09PM EDT
Day High/Low3.45 - 3.71
52 Week High/Low2.56 - 5.85
Open / Close3.45 / 3.68
Float / Outstanding23.6M / 24.3M
Vol / Avg.109.6K / 119.7K
Mkt Cap89.5M
P/E-
50d Avg. Price3.59
Div / Yield-
Payout Ratio-
EPS-0.32
Total Float23.6M

Capricor Therapeutics (NASDAQ:CAPR), Quotes and News Summary

Capricor Therapeutics (NASDAQ: CAPR)

Day High/Low3.45 - 3.71
52 Week High/Low2.56 - 5.85
Open / Close3.45 / 3.68
Float / Outstanding23.6M / 24.3M
Vol / Avg.109.6K / 119.7K
Mkt Cap89.5M
P/E-
50d Avg. Price3.59
Div / Yield-
Payout Ratio-
EPS-0.32
Total Float23.6M
Benzinga - 6 days ago
Benzinga - May 10, 2022, 4:09PM
Benzinga - Mar 28, 2022, 12:06PM
Benzinga - Mar 28, 2022, 11:10AM
Benzinga - Mar 28, 2022, 8:33AM
Benzinga - Mar 11, 2022, 1:29PM
Benzinga - Mar 10, 2022, 4:42PM
Benzinga - Mar 10, 2022, 4:24PM
Benzinga - Jan 31, 2022, 9:29AM
Benzinga - Jan 25, 2022, 3:32PM
Benzinga - Jan 25, 2022, 11:06AM
Benzinga - Jan 25, 2022, 5:04AM
Benzinga - Dec 13, 2021, 9:18AM
Benzinga - Nov 9, 2021, 5:28PM
Benzinga - Oct 11, 2021, 6:19AM
load more
Sector: Health Care.Industry: Biotechnology
Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q1 2022Est.ActualSurprise
EPS-0.320
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Capricor Therapeutics Questions & Answers

Q
How do I buy Capricor Therapeutics (CAPR) stock?
A

You can purchase shares of Capricor Therapeutics (NASDAQ: CAPR) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Capricor Therapeutics's (CAPR) competitors?
Q
What is the target price for Capricor Therapeutics (CAPR) stock?
A

The latest price target for Capricor Therapeutics (NASDAQ: CAPR) was reported by HC Wainwright & Co. on Monday, January 31, 2022. The analyst firm set a price target for 18.00 expecting CAPR to rise to within 12 months (a possible 389.13% upside). 2 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Capricor Therapeutics (CAPR)?
A

The stock price for Capricor Therapeutics (NASDAQ: CAPR) is $3.68 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Capricor Therapeutics (CAPR) pay a dividend?
A

There are no upcoming dividends for Capricor Therapeutics.

Q
When is Capricor Therapeutics (NASDAQ:CAPR) reporting earnings?
A

Capricor Therapeutics’s Q2 earnings are confirmed for Thursday, August 11, 2022.

Q
Is Capricor Therapeutics (CAPR) going to split?
A

There is no upcoming split for Capricor Therapeutics.

Q
What sector and industry does Capricor Therapeutics (CAPR) operate in?
A

Capricor Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.